United States Biotechnology & Medical Research

Oldtech Inc (EYET)

Track

Ticker: EYET Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
CHANEY PAUL G Chief Operating Officer Officer
Transaction date
Sale
Price
54.46
Quantity 30,807 -30.4%
Value US$119,870
CHANEY PAUL G Chief Operating Officer Officer
Transaction date
Sale
Price
374.87
Quantity 55,106 -19.9%
Value US$4,401,506
SBLENDORIO GLENN Chief Financial Officer Officer
Transaction date
Sale
Price
137.12
Quantity 93,853 +36.1%
Value US$3,084,417
SBLENDORIO GLENN Chief Financial Officer Officer
Transaction date
Sale
Price
17.63
Quantity 52,500 -54.9%
Value US$925,575
ADAMIS ANTHONY P Chief Scientific Officer Officer
Transaction date
Sale
Price
17.68
Quantity 106,094 -49.1%
Value US$1,875,742
SBLENDORIO GLENN Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.35
Quantity 1,850 -4.1%
Value US$20,998
SBLENDORIO GLENN Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.35
Quantity 1,850 -4.1%
Value US$20,998
CHANEY PAUL G Chief Operating Officer Officer
Transaction date
Planned sale
Price
11.33
Quantity 2,800 -8.4%
Value US$31,724
ADAMIS ANTHONY P Chief Scientific Officer Officer
Transaction date
Planned sale
Price
11.35
Quantity 5,325 -4.6%
Value US$60,439
GUYER DAVID R Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
11.33
Quantity 15,600 -1.3%
Value US$176,748
GUYER DAVID R Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
12.56
Quantity 15,600 -1.3%
Value US$195,936
SBLENDORIO GLENN Chief Financial Officer Officer
Transaction date
Planned sale
Price
12.59
Quantity 1,850 -4.1%
Value US$23,292
SBLENDORIO GLENN Chief Financial Officer Officer
Transaction date
Planned sale
Price
12.59
Quantity 1,850 -4.1%
Value US$23,292
ADAMIS ANTHONY P Chief Scientific Officer Officer
Transaction date
Planned sale
Price
12.59
Quantity 5,325 -4.4%
Value US$67,042
CHANEY PAUL G Chief Operating Officer Officer
Transaction date
Planned sale
Price
12.68
Quantity 2,800 -8.4%
Value US$35,504
GUYER DAVID R Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
12.95
Quantity 15,600 -1.4%
Value US$202,020
CHANEY PAUL G Chief Operating Officer Officer
Transaction date
Planned sale
Price
12.98
Quantity 2,800 -82.5%
Value US$36,344
SBLENDORIO GLENN Chief Financial Officer Officer
Transaction date
Planned sale
Price
12.94
Quantity 1,850 -75.7%
Value US$23,939
SBLENDORIO GLENN Chief Financial Officer Officer
Transaction date
Planned sale
Price
12.94
Quantity 1,850 -75.7%
Value US$23,939
ADAMIS ANTHONY P Chief Scientific Officer Officer
Transaction date
Planned sale
Price
12.95
Quantity 5,325 -15.9%
Value US$68,959
PATEL SAMIR CHANDRAKANT Chief Commercial & Medical Executive Director
Transaction date
Planned sale
Price
23.73
Quantity 50,000 -22.3%
Value US$1,186,500
PATEL SAMIR CHANDRAKANT Chief Commercial & Medical Executive Director
Transaction date
Planned sale
Price
27.50
Quantity 50,000 -18.2%
Value US$1,375,000
PATEL SAMIR CHANDRAKANT Chief Commercial & Medical Executive Director
Transaction date
Planned sale
Price
32.78
Quantity 50,000 -15.4%
Value US$1,639,000
GUYER DAVID R Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
35.97
Quantity 100,000 -8.4%
Value US$3,597,000
GLICK MARTY Non-Executive Director
Transaction date
Sale
Price
36.15
Quantity 6,600 -1.2%
Value US$238,590
PATEL SAMIR CHANDRAKANT Chief Commercial & Medical Executive Director
Transaction date
Planned sale
Price
36.07
Quantity 20,000 -5.8%
Value US$721,400
CHANEY PAUL G Chief Operating Officer Officer
Transaction date
Sale
Price
36.45
Quantity 4,000 -100.0%
Value US$145,800
PATEL SAMIR CHANDRAKANT Chief Commercial & Medical Executive Director
Transaction date
Sale
Price
39.83
Quantity 50,000 -12.7%
Value US$1,991,500
ADAMIS ANTHONY P Chief Scientific Officer Officer
Transaction date
Planned sale
Price
43.45
Quantity 8,212 -29.8%
Value US$356,811
PATEL SAMIR CHANDRAKANT Chief Commercial & Medical Executive Director
Transaction date
Planned sale
Price
44.71
Quantity 20,000 -4.8%
Value US$894,200
GUYER DAVID R Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
44.70
Quantity 40,000 -3.3%
Value US$1,788,000
ADAMIS ANTHONY P Chief Scientific Officer Officer
Transaction date
Planned sale
Price
45.21
Quantity 8,212 -29.8%
Value US$371,265
CHANEY PAUL G Chief Operating Officer Officer
Transaction date
Planned sale
Price
45.19
Quantity 4,000 -100.0%
Value US$180,760
GUYER DAVID R Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
41.88
Quantity 40,000 -3.2%
Value US$1,675,200
PATEL SAMIR CHANDRAKANT Non-Executive Director
Transaction date
Planned sale
Price
43.58
Quantity 20,000 -4.6%
Value US$871,600
ALTSCHULER DOUGLAS H Sr VP, Legal, General Counsel Officer
Transaction date
Sale
Price
43.58
Quantity 21,024 -98.4%
Value US$916,226
ALTSCHULER DOUGLAS H Sr VP, Legal, General Counsel Officer
Transaction date
Sale
Price
43.58
Quantity 2,976 -89.9%
Value US$129,694
ALTSCHULER DOUGLAS H Sr VP, Legal, General Counsel Officer
Transaction date
Sale
Price
43.58
Quantity 8,000 -96.0%
Value US$348,640
CHANEY PAUL G Chief Operating Officer Officer
Transaction date
Planned sale
Price
40.30
Quantity 4,000 -100.0%
Value US$161,200
PENHOET EDWARD No longer a Director
Transaction date
Sale
Price
45.41
Quantity 1,041 -28.6%
Value US$47,275
PENHOET EDWARD No longer a Director
Transaction date
Sale
Price
45.41
Quantity 13,750 -79.0%
Value US$624,436
SBLENDORIO GLENN Chief Financial Officer Officer
Transaction date
Planned sale
Price
45.17
Quantity 5,000 -100.0%
Value US$225,850
CHANEY PAUL G Chief Operating Officer Officer
Transaction date
Sale
Price
0.00
Quantity 4,000
Value US$0
WICKER DAMION E MD
Transaction date
Sale
Price
41.26
Quantity 1,000,000 -30.9%
Value US$41,260,000
JP MORGAN PARTNERS BHCA LP Large shareholder
Transaction date
Sale
Price
41.26
Quantity 1,000,000 -30.9%
Value US$41,260,000
ALTSCHULER DOUGLAS H Sr VP, Legal, General Counsel
Transaction date
Sale
Price
43.31
Quantity 32,500 -79.6%
Value US$1,407,575
ALTSCHULER DOUGLAS H Sr VP, Legal, General Counsel
Transaction date
Sale
Price
42.09
Quantity 2,500 -23.1%
Value US$105,225
ALTSCHULER DOUGLAS H Sr VP, Legal, General Counsel
Transaction date
Sale
Price
42.09
Quantity 10,000 -54.5%
Value US$420,900
0.6
SBLENDORIO GLENN Chief Financial Officer
Transaction date
Sale
Price
41.25
Quantity 7,500 -100.0%
Value US$309,375
CHANEY PAUL G Chief Operating Officer
Transaction date
Sale
Price
33.22
Quantity 15,000 -100.0%
Value US$498,300
CHANEY PAUL G Chief Operating Officer Officer
Transaction date
Sale
Price
34.96
Quantity 15,000 -100.0%
Value US$524,400
WICKER DAMION E MD Non-Executive Director
Transaction date
Sale
Price
38.50
Quantity 810,223 -20.0%
Value US$31,193,586
JP MORGAN PARTNERS BHCA LP Large shareholder
Transaction date
Sale
Price
38.50
Quantity 810,223 -20.0%
Value US$31,193,586
PENHOET EDWARD Non-Executive Director
Transaction date
Sale
Price
36.50
Quantity 10,179 -27.2%
Value US$371,534
PENHOET EDWARD Non-Executive Director
Transaction date
Sale
Price
36.50
Quantity 339,971 -27.2%
Value US$12,408,942
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2005-11-07 2005-11-04 S Sale CHANEY PAUL G

Chief Operating Officer

Officer
30,807 -30.4%
54.46
US$119,870 		30,807 -30.4% 54.46 US$119,870
2005-11-07 2005-11-04 S Sale CHANEY PAUL G

Chief Operating Officer

Officer
55,106 -19.9%
374.87
US$4,401,506 		55,106 -19.9% 374.87 US$4,401,506
2005-11-07 2005-11-04 S Sale SBLENDORIO GLENN

Chief Financial Officer

Officer
93,853 +36.1%
137.12
US$3,084,417 		93,853 +36.1% 137.12 US$3,084,417
2005-11-07 2005-11-03 S Sale SBLENDORIO GLENN

Chief Financial Officer

Officer
52,500 -54.9%
17.63
US$925,575 		52,500 -54.9% 17.63 US$925,575
2005-11-07 2005-11-03 S Sale ADAMIS ANTHONY P

Chief Scientific Officer

Officer
106,094 -49.1%
17.68
US$1,875,742 		106,094 -49.1% 17.68 US$1,875,742
2005-08-01 2005-08-01 PlS Planned sale SBLENDORIO GLENN

Chief Financial Officer

Officer
1,850 -4.1%
11.35
US$20,998 		1,850 -4.1% 11.35 US$20,998
2005-08-01 2005-08-01 PlS Planned sale SBLENDORIO GLENN

Chief Financial Officer

Officer
1,850 -4.1%
11.35
US$20,998 		1,850 -4.1% 11.35 US$20,998
2005-08-01 2005-08-01 PlS Planned sale CHANEY PAUL G

Chief Operating Officer

Officer
2,800 -8.4%
11.33
US$31,724 		2,800 -8.4% 11.33 US$31,724
2005-08-01 2005-08-01 PlS Planned sale ADAMIS ANTHONY P

Chief Scientific Officer

Officer
5,325 -4.6%
11.35
US$60,439 		5,325 -4.6% 11.35 US$60,439
2005-08-01 2005-08-01 PlS Planned sale GUYER DAVID R

Chief Executive Officer

Executive Director
15,600 -1.3%
11.33
US$176,748 		15,600 -1.3% 11.33 US$176,748
2005-07-01 2005-07-01 PlS Planned sale GUYER DAVID R

Chief Executive Officer

Executive Director
15,600 -1.3%
12.56
US$195,936 		15,600 -1.3% 12.56 US$195,936
2005-07-01 2005-07-01 PlS Planned sale SBLENDORIO GLENN

Chief Financial Officer

Officer
1,850 -4.1%
12.59
US$23,292 		1,850 -4.1% 12.59 US$23,292
2005-07-01 2005-07-01 PlS Planned sale SBLENDORIO GLENN

Chief Financial Officer

Officer
1,850 -4.1%
12.59
US$23,292 		1,850 -4.1% 12.59 US$23,292
2005-07-01 2005-07-01 PlS Planned sale ADAMIS ANTHONY P

Chief Scientific Officer

Officer
5,325 -4.4%
12.59
US$67,042 		5,325 -4.4% 12.59 US$67,042
2005-07-01 2005-07-01 PlS Planned sale CHANEY PAUL G

Chief Operating Officer

Officer
2,800 -8.4%
12.68
US$35,504 		2,800 -8.4% 12.68 US$35,504
2005-06-03 2005-06-01 PlS Planned sale GUYER DAVID R

Chief Executive Officer

Executive Director
15,600 -1.4%
12.95
US$202,020 		15,600 -1.4% 12.95 US$202,020
2005-06-03 2005-06-01 PlS Planned sale CHANEY PAUL G

Chief Operating Officer

Officer
2,800 -82.5%
12.98
US$36,344 		2,800 -82.5% 12.98 US$36,344
2005-06-03 2005-06-01 PlS Planned sale SBLENDORIO GLENN

Chief Financial Officer

Officer
1,850 -75.7%
12.94
US$23,939 		1,850 -75.7% 12.94 US$23,939
2005-06-03 2005-06-01 PlS Planned sale SBLENDORIO GLENN

Chief Financial Officer

Officer
1,850 -75.7%
12.94
US$23,939 		1,850 -75.7% 12.94 US$23,939
2005-06-03 2005-06-01 PlS Planned sale ADAMIS ANTHONY P

Chief Scientific Officer

Officer
5,325 -15.9%
12.95
US$68,959 		5,325 -15.9% 12.95 US$68,959
2005-05-03 2005-05-02 PlS Planned sale PATEL SAMIR CHANDRAKANT

Chief Commercial & Medical

Executive Director
50,000 -22.3%
23.73
US$1,186,500 		50,000 -22.3% 23.73 US$1,186,500
2005-04-01 2005-04-01 PlS Planned sale PATEL SAMIR CHANDRAKANT

Chief Commercial & Medical

Executive Director
50,000 -18.2%
27.50
US$1,375,000 		50,000 -18.2% 27.50 US$1,375,000
2005-03-01 2005-03-01 PlS Planned sale PATEL SAMIR CHANDRAKANT

Chief Commercial & Medical

Executive Director
50,000 -15.4%
32.78
US$1,639,000 		50,000 -15.4% 32.78 US$1,639,000
2005-02-03 2005-02-01 PlS Planned sale GUYER DAVID R

Chief Executive Officer

Executive Director
100,000 -8.4%
35.97
US$3,597,000 		100,000 -8.4% 35.97 US$3,597,000
2005-02-02 2005-02-01 S Sale GLICK MARTY Non-Executive Director
6,600 -1.2%
36.15
US$238,590 		6,600 -1.2% 36.15 US$238,590
2005-02-02 2005-02-01 PlS Planned sale PATEL SAMIR CHANDRAKANT

Chief Commercial & Medical

Executive Director
20,000 -5.8%
36.07
US$721,400 		20,000 -5.8% 36.07 US$721,400
2005-02-02 2005-01-31 S Sale CHANEY PAUL G

Chief Operating Officer

Officer
4,000 -100.0%
36.45
US$145,800 		4,000 -100.0% 36.45 US$145,800
2005-01-20 2005-01-19 S Sale PATEL SAMIR CHANDRAKANT

Chief Commercial & Medical

Executive Director
50,000 -12.7%
39.83
US$1,991,500 		50,000 -12.7% 39.83 US$1,991,500
2005-01-05 2005-01-04 PlS Planned sale ADAMIS ANTHONY P

Chief Scientific Officer

Officer
8,212 -29.8%
43.45
US$356,811 		8,212 -29.8% 43.45 US$356,811
2005-01-13 2005-01-03 PlS Planned sale PATEL SAMIR CHANDRAKANT

Chief Commercial & Medical

Executive Director
20,000 -4.8%
44.71
US$894,200 		20,000 -4.8% 44.71 US$894,200
2005-01-13 2005-01-03 PlS Planned sale GUYER DAVID R

Chief Executive Officer

Executive Director
40,000 -3.3%
44.70
US$1,788,000 		40,000 -3.3% 44.70 US$1,788,000
2005-01-05 2005-01-03 PlS Planned sale ADAMIS ANTHONY P

Chief Scientific Officer

Officer
8,212 -29.8%
45.21
US$371,265 		8,212 -29.8% 45.21 US$371,265
2005-01-04 2004-12-31 PlS Planned sale CHANEY PAUL G

Chief Operating Officer

Officer
4,000 -100.0%
45.19
US$180,760 		4,000 -100.0% 45.19 US$180,760
2004-12-21 2004-12-21 PlS Planned sale GUYER DAVID R

Chief Executive Officer

Executive Director
40,000 -3.2%
41.88
US$1,675,200 		40,000 -3.2% 41.88 US$1,675,200
2004-12-21 2004-12-20 PlS Planned sale PATEL SAMIR CHANDRAKANT Non-Executive Director
20,000 -4.6%
43.58
US$871,600 		20,000 -4.6% 43.58 US$871,600
2004-12-21 2004-12-20 S Sale ALTSCHULER DOUGLAS H

Sr VP, Legal, General Counsel

Officer
21,024 -98.4%
43.58
US$916,226 		21,024 -98.4% 43.58 US$916,226
2004-12-21 2004-12-20 S Sale ALTSCHULER DOUGLAS H

Sr VP, Legal, General Counsel

Officer
2,976 -89.9%
43.58
US$129,694 		2,976 -89.9% 43.58 US$129,694
2004-12-21 2004-12-20 S Sale ALTSCHULER DOUGLAS H

Sr VP, Legal, General Counsel

Officer
8,000 -96.0%
43.58
US$348,640 		8,000 -96.0% 43.58 US$348,640
2004-11-30 2004-11-30 PlS Planned sale CHANEY PAUL G

Chief Operating Officer

Officer
4,000 -100.0%
40.30
US$161,200 		4,000 -100.0% 40.30 US$161,200
2004-11-17 2004-11-17 S Sale PENHOET EDWARD

No longer a Director
1,041 -28.6%
45.41
US$47,275 		1,041 -28.6% 45.41 US$47,275
2004-11-17 2004-11-17 S Sale PENHOET EDWARD

No longer a Director
13,750 -79.0%
45.41
US$624,436 		13,750 -79.0% 45.41 US$624,436
2004-11-17 2004-11-16 PlS Planned sale SBLENDORIO GLENN

Chief Financial Officer

Officer
5,000 -100.0%
45.17
US$225,850 		5,000 -100.0% 45.17 US$225,850
2004-11-01 2004-10-29 S Sale CHANEY PAUL G

Chief Operating Officer

Officer
4,000
0.00
US$0 		4,000 0.00 US$0
2004-10-29 2004-10-28 S Sale
WICKER DAMION E MD
1,000,000 -30.9%
41.26
US$41,260,000 		1,000,000 -30.9% 41.26 US$41,260,000
2004-10-29 2004-10-28 S Sale
JP MORGAN PARTNERS BHCA LP
Large shareholder
1,000,000 -30.9%
41.26
US$41,260,000 		1,000,000 -30.9% 41.26 US$41,260,000
2004-10-18 2004-10-15 S Sale
ALTSCHULER DOUGLAS H

Sr VP, Legal, General Counsel
32,500 -79.6%
43.31
US$1,407,575 		32,500 -79.6% 43.31 US$1,407,575
2004-10-18 2004-10-14 S Sale
ALTSCHULER DOUGLAS H

Sr VP, Legal, General Counsel
2,500 -23.1%
42.09
US$105,225 		2,500 -23.1% 42.09 US$105,225
2004-10-18 2004-10-14 S Sale
ALTSCHULER DOUGLAS H

Sr VP, Legal, General Counsel
10,000 -54.5%
42.09
US$420,900 		10,000 -54.5% 42.09 US$420,900
2004-10-15 2004-10-14 S Sale
0.6
SBLENDORIO GLENN

Chief Financial Officer
7,500 -100.0%
41.25
US$309,375 		7,500 -100.0% 41.25 US$309,375
2004-10-01 2004-09-30 S Sale
CHANEY PAUL G

Chief Operating Officer
15,000 -100.0%
33.22
US$498,300 		15,000 -100.0% 33.22 US$498,300
2004-08-31 2004-08-31 S Sale CHANEY PAUL G

Chief Operating Officer

Officer
15,000 -100.0%
34.96
US$524,400 		15,000 -100.0% 34.96 US$524,400
2004-06-04 2004-06-02 S Sale WICKER DAMION E MD Non-Executive Director
810,223 -20.0%
38.50
US$31,193,586 		810,223 -20.0% 38.50 US$31,193,586
2004-06-04 2004-06-02 S Sale JP MORGAN PARTNERS BHCA LP Large shareholder
810,223 -20.0%
38.50
US$31,193,586 		810,223 -20.0% 38.50 US$31,193,586
2004-06-02 2004-05-26 S Sale PENHOET EDWARD Non-Executive Director
10,179 -27.2%
36.50
US$371,534 		10,179 -27.2% 36.50 US$371,534
2004-06-02 2004-05-26 S Sale PENHOET EDWARD Non-Executive Director
339,971 -27.2%
36.50
US$12,408,942 		339,971 -27.2% 36.50 US$12,408,942
Explore more

More insider trading research around Oldtech Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America